375 related articles for article (PubMed ID: 30921775)
1. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
[TBL] [Abstract][Full Text] [Related]
2. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
[TBL] [Abstract][Full Text] [Related]
3. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
[TBL] [Abstract][Full Text] [Related]
4. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the effect of setup uncertainty reduction and adaptation to geometric changes on normal tissue complication probability using online adaptive head and neck intensity modulated proton therapy.
Lalonde A; Bobić M; Sharp GC; Chamseddine I; Winey B; Paganetti H
Phys Med Biol; 2023 May; 68(11):. PubMed ID: 37164020
[No Abstract] [Full Text] [Related]
6. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy - A proton versus photon comparison.
De Ornelas M; Iorio GC; Bossart E; Ricardi U; Seldon C; Dal Pra A; Butkus M
Phys Med; 2023 Aug; 112():102644. PubMed ID: 37487297
[TBL] [Abstract][Full Text] [Related]
8. The price of robustness; impact of worst-case optimization on organ-at-risk dose and complication probability in intensity-modulated proton therapy for oropharyngeal cancer patients.
van de Water S; van Dam I; Schaart DR; Al-Mamgani A; Heijmen BJ; Hoogeman MS
Radiother Oncol; 2016 Jul; 120(1):56-62. PubMed ID: 27178142
[TBL] [Abstract][Full Text] [Related]
9. Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.
Teoh S; George B; Fiorini F; Vallis KA; Van den Heuvel F
Br J Radiol; 2020 Mar; 93(1107):20190584. PubMed ID: 31977241
[TBL] [Abstract][Full Text] [Related]
10. Assessment of IMPT versus VMAT plans using different uncertainty scenarios for prostate cancer.
Butkus MP; Brovold N; Diwanji T; Xu Y; De Ornelas M; Dal Pra A; Abramowitz M; Pollack A; Dogan N
Radiat Oncol; 2022 Sep; 17(1):162. PubMed ID: 36175971
[TBL] [Abstract][Full Text] [Related]
11. Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy.
Bijman RG; Breedveld S; Arts T; Astreinidou E; de Jong MA; Granton PV; Petit SF; Hoogeman MS
Acta Oncol; 2017 Nov; 56(11):1444-1450. PubMed ID: 28828923
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
13. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
14. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
15. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
16. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
[No Abstract] [Full Text] [Related]
17. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
18. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
An Y; Liang J; Schild SE; Bues M; Liu W
Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
[TBL] [Abstract][Full Text] [Related]
19. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
20. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
